Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,203.55
-4.8 (-0.22%)
BSENSE

Dec 05

BSE+NSE Vol: 3.06 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
3,697.16
3,570.35
3,079.37
3,198.79
3,061.43
2,867.85
2,422.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,697.16
3,570.35
3,079.37
3,198.79
3,061.43
2,867.85
2,422.24
Raw Material Cost
594.36
585.68
554.25
532.40
459.82
469.88
433.80
Purchase of Finished goods
412.97
404.97
411.12
387.30
424.28
432.99
342.29
(Increase) / Decrease In Stocks
54.84
62.94
-89.99
11.81
-11.38
-93.44
-41.34
Employee Cost
825.18
783.41
715.80
704.75
642.12
629.70
577.94
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
888.48
886.58
805.00
746.54
699.40
757.16
523.25
Total Expenditure (Excl Depreciation)
2,775.83
2,723.58
2,396.18
2,382.80
2,214.24
2,196.29
1,835.94
Operating Profit (PBDIT) excl Other Income
921.33
846.77
683.19
815.99
847.19
671.56
586.30
Other Income
91.87
79.88
251.33
77.00
109.06
99.40
92.15
Operating Profit (PBDIT)
1,013.20
926.65
934.52
892.99
956.25
770.96
678.45
Interest
169.68
170.65
190.54
220.93
7.10
10.84
9.17
Exceptional Items
0.00
0.00
-4.34
6.65
-2.37
4.59
-0.33
Gross Profit (PBDT)
843.52
756.00
743.98
672.06
949.15
760.12
669.28
Depreciation
221.82
218.68
230.87
187.17
100.49
102.69
99.78
Profit Before Tax
624.02
540.49
515.43
488.33
851.23
661.34
571.91
Tax
103.84
95.87
86.44
110.46
189.98
122.86
94.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
517.86
441.45
426.67
374.43
658.68
534.57
474.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
-4.34
6.65
-2.37
4.59
-0.33
Net Profit
517.86
441.45
422.33
381.08
656.31
539.16
474.18
Share in Profit of Associates
2.32
3.17
2.32
3.44
2.57
3.91
2.41
Minority Interest
8.67
6.30
3.88
4.29
5.41
6.58
5.35
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
511.51
438.32
420.77
380.23
653.47
536.49
471.24
Equity Capital
41.28
41.26
41.26
40.06
40.06
40.06
40.06
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.39
10.62
10.2
9.49
16.31
13.39
11.76
Diluted Earnings per share
12.38
10.6
10.18
9.44
16.28
13.37
11.74
Operating Profit Margin (Excl OI)
24.92%
23.72%
22.19%
25.51%
27.67%
23.42%
24.2%
Gross Profit Margin
22.82%
21.17%
24.16%
21.01%
31.0%
26.5%
27.63%
PAT Margin
14.07%
12.45%
13.93%
11.81%
21.6%
18.78%
19.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 3.55% vs 15.94% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 16.70% vs 4.17% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 8.81% vs 23.94% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -0.57% vs -10.44% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Mankind Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
3,697.16
6,123.20
-2,426.04
-39.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,697.16
6,123.20
-2,426.04
-39.62%
Raw Material Cost
594.36
1,327.10
-732.74
-55.21%
Purchase of Finished goods
412.97
589.10
-176.13
-29.90%
(Increase) / Decrease In Stocks
54.84
-225.70
280.54
124.30%
Employee Cost
825.18
1,034.20
-209.02
-20.21%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
888.48
1,382.70
-494.22
-35.74%
Total Expenditure (Excl Depreciation)
2,775.83
4,107.40
-1,331.57
-32.42%
Operating Profit (PBDIT) excl Other Income
921.33
2,015.80
-1,094.47
-54.29%
Other Income
91.87
109.00
-17.13
-15.72%
Operating Profit (PBDIT)
1,013.20
2,124.80
-1,111.60
-52.32%
Interest
169.68
101.30
68.38
67.50%
Exceptional Items
0.00
-34.20
34.20
100.00%
Gross Profit (PBDT)
843.52
1,989.30
-1,145.78
-57.60%
Depreciation
221.82
301.90
-80.08
-26.53%
Profit Before Tax
624.02
1,687.40
-1,063.38
-63.02%
Tax
103.84
454.00
-350.16
-77.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
517.86
1,233.40
-715.54
-58.01%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
517.86
1,233.40
-715.54
-58.01%
Share in Profit of Associates
2.32
5.20
-2.88
-55.38%
Minority Interest
8.67
-20.00
28.67
143.35%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
511.51
1,258.60
-747.09
-59.36%
Equity Capital
41.28
100.60
-59.32
-58.97%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.39
12.51
-0.12
-0.96%
Diluted Earnings per share
12.38
12.51
-0.13
-1.04%
Operating Profit Margin (Excl OI)
24.92%
33.39%
0.00
-8.47%
Gross Profit Margin
22.82%
32.95%
0.00
-10.13%
PAT Margin
14.07%
20.43%
0.00
-6.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,697.16 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.55% vs 15.94% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.77% vs 13.05% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 511.51 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 16.70% vs 4.17% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -21.72% vs 30.43% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 921.33 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.81% vs 23.94% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 8.75% vs 24.10% in Sep 2024

Quarterly - Interest
Interest 169.68 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -0.57% vs -10.44% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 2,289.86% vs -17.63% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.92%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024